ALK/IGF1R inhibitor
- CAS NO.:1356962-20-3
- Empirical Formula: C24H25ClN6O
- Molecular Weight: 448.95
- MDL number: MFCD25976759
- SAFETY DATA SHEET (SDS)
- Update Date: 2024-11-19 23:02:33
What is ALK/IGF1R inhibitor?
The Uses of ALK/IGF1R inhibitor
AZD3463, is a novel ALK/IGF1R dual Inhibitor, having the ability of overcoming multiple mechanisms of acquired resistance to Crizotinib (C785000).
Definition
ChEBI: AZD3463 is a member of the class of indoles that is 1H-indole substituted by a 2-[4-(4-aminopiperidin-1-yl)-2-methoxyanilino]-5-chloropyrimidin-4-yl group at position 3. It is an orally bioavailable dual inhibitor of ALK and IGF1R with Ki value of 0.75 nM for ALK. It has a role as an apoptosis inducer, an antineoplastic agent, an EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor and an autophagy inducer. It is a member of indoles, an aminopiperidine, a monomethoxybenzene, an aminopyrimidine, a secondary amino compound, a tertiary amino compound and an organochlorine compound.
Biological Activity
azd3463 is a novel orally bioavailable alk/igf1r inhibitor with ki value of 0.75 nm. alk expression is largely restricted to neurons and upregulated in neuroblastoma. activated alk has been shown to promote cell survival and growth. high alk expression or mutations in the alk gene correlates with adverse outcomes in neuroblastoma. therefore, alk receptor tyrosine kinase is an important therapeutic target for drug development against neuroblastoma [1].
in vitro
azd3463 (5, 10, 20, and 50 μm) effectively inhibited the proliferation of neuroblastoma cell lines with wild type alk (wt) and alk activating mutations (f1174l and d1091n) via targeting the alk-mediated pi3k/akt/mtor pathway and ultimately induced apoptosis and autophagy in vitro. moreover, azd3463 (1 μm) significantly enhanced the cytotoxic effects of doxorubicin (1 μm) on neuroblastoma cells [1]. azd3463 simultaneously inhibited stat3 and akt to augment the cytotoxic effects of temozolomide and further reduce cell growth [2].
in vivo
azd3463 (15 mg/kg, i.p. injection) showed significant therapeutic efficacy on the growth of the neuroblastoma tumors with wt and f1174l oncogenic mutant alk in orthotopic xenograft mouse models [1].
References
1. wang y, wang l, guan s, cao w, wang h, chen z, et al. novel alk inhibitor azd3463 inhibits neuroblastoma growth by overcoming crizotinib resistance and inducing apoptosis. sci rep. 2016;6:19423. 2. sampson vb, vetter ns, kamara df, collier ab, gresh rc, kolb ea. vorinostat enhances cytotoxicity of sn-38 and temozolomide in ewing sarcoma cells and activates stat3/akt/mapk pathways. plos one. 2015;10(11):e0142704.
Properties of ALK/IGF1R inhibitor
Boiling point: | 723.6±70.0 °C(Predicted) |
Density | 1.338±0.06 g/cm3(Predicted) |
storage temp. | Store at -20°C |
solubility | insoluble in H2O; insoluble in EtOH; ≥11.22 mg/mL in DMSO |
form | solid |
pka | 14.62±0.30(Predicted) |
color | Light green to green |
Safety information for ALK/IGF1R inhibitor
Computed Descriptors for ALK/IGF1R inhibitor
New Products
4-AMINO-TETRAHYDRO-PYRAN-4-CARBOXYLIC ACID HCL 4-(Dimethylamino)tetrahydro-2H-pyran-4-carbonitrile 4-Aminotetrahydropyran-4-carbonitrile Hydrochloride (R)-3-Aminobutanenitrile Hydrochloride 3-((Dimethylamino)methyl)-5-methylhexan-2-one oxalate 1,4-Dioxa-8-azaspiro[4.5]decane 5-Bromo-2-nitropyridine Nimesulide BP Aceclofenac IP/BP/EP Diclofenac Sodium IP/BP/EP/USP Mefenamic Acid IP/BP/EP/USP Ornidazole IP Diclofenac Potassium THOMAIND PAPER PH 2.0 TO 4.5 1 BOX BUFFER CAPSULE PH 9.2 - 10 CAP SODIUM CHLORIDE 0.1N CVS ALLOXAN MONOHYDRATE 98% PLATINUM 0.5% ON 3 MM ALUMINA PELLETS (TYPE 73) LITHIUM AAS SOLUTION 2-Bromo-1-(bromomethyl)-3-chloro-5-nitrobenzene 2-Bromo-3-nitroaniline N-(3-Hydroxypropyl)-N-methylacetamide 3-Bromo-6-chloropyridazine 4-ethyl-3-nitrobenzoic acidRelated products of tetrahydrofuran
You may like
-
AZD3463 >95% CAS 1356962-20-3View Details
1356962-20-3 -
AZD3463 CAS 1356962-20-3View Details
1356962-20-3 -
1823368-42-8 98%View Details
1823368-42-8 -
2-(3-(tert-butyl)phenoxy)-2-methylpropanoic acid 1307449-08-6 98%View Details
1307449-08-6 -
Ethyl 3-(furan-2-yl)-3-hydroxypropanoate 25408-95-1 98%View Details
25408-95-1 -
2-Chloro-5-fluoro-1-methoxy-3-methylbenzene 98%View Details
1805639-70-6 -
1784294-80-9 98%View Details
1784294-80-9 -
Lithium ClavulanateView Details
61177-44-4